The use and the cost of outpatient diagnostic procedures for cardiovascular diseases in Isfahan province: A utilization study.

Cardiovascular diseases The use and the cost of outpatient diagnostic procedures for CVDs are increasing drastically. Since 2011 the use of and its related costs have increased about 7 and 31 times (about 12 times adjusted with PPP conversion factor) respectively. Besides CVD control programs appropriate cost containment policies should be adopted. cost outpatient utilization study

Journal

Journal of education and health promotion
ISSN: 2277-9531
Titre abrégé: J Educ Health Promot
Pays: India
ID NLM: 101593794

Informations de publication

Date de publication:
2022
Historique:
received: 02 12 2021
accepted: 28 02 2022
entrez: 30 9 2022
pubmed: 1 10 2022
medline: 1 10 2022
Statut: epublish

Résumé

Cardiovascular diseases (CVDs) are among the most important causes of premature death, disability, disease burden, and increasing the cost of healthcare worldwide. Having an overview of service utilization can help policymakers to plan more effective use of those services and to cut costs. Thus, this study aims to determine the amount of use as well as the cost of various outpatient diagnostic procedures for CVDs in Isfahan province of Iran from 2011 to 2017. This descriptive study used insurance claim data (time period: 2011-2017) from Health Insurance Organization in Isfahan province to determine the amount of use and the cost of various outpatient diagnostic procedures for CVDs. Afterward, based on these data, the use and the cost of various outpatient diagnostic procedures for CVDs were estimated for the total population of Isfahan province. The list of outpatient diagnostic procedures for CVDs was carefully chosen according to experts' opinions. The use and the cost of outpatient diagnostic procedures for CVDs have drastically increased in the study period (2011-2017). Since 2011, the number of procedures and their related costs have increased 6.6 and 30.76 times (11.74 times, adjusted with PPP conversion factor), respectively. Per capita use (per thousand people) was 18.75 in 2011, reaching 116.51 in 2017. Per capita cost (per thousand people) was 1,887,660 IRR (355 PPP$) in 2011, reaching 54,660,365 IRR (3920 PPP$) in 2017. The highest cost and use were related to echocardiography and electrocardiography, respectively. A notable increase has been observed in the share of radionuclide myocardial perfusion scan and analysis of pacemakers and ICDs of the total cost. The use of outpatient diagnostic procedures for CVDs has drastically increased during the studied period. Consequently, the cost borne by the health system and the patients have notably increased. This may be because of the increase in the incidence and prevalence of CVDs during the study period. Greater access to related health services can be mentioned as another reason for this increase. Further research is needed to explain all potential reasons and their importance, which can provoke a suitable health policy reaction.

Sections du résumé

BACKGROUND BACKGROUND
Cardiovascular diseases (CVDs) are among the most important causes of premature death, disability, disease burden, and increasing the cost of healthcare worldwide. Having an overview of service utilization can help policymakers to plan more effective use of those services and to cut costs. Thus, this study aims to determine the amount of use as well as the cost of various outpatient diagnostic procedures for CVDs in Isfahan province of Iran from 2011 to 2017.
MATERIALS AND METHODS METHODS
This descriptive study used insurance claim data (time period: 2011-2017) from Health Insurance Organization in Isfahan province to determine the amount of use and the cost of various outpatient diagnostic procedures for CVDs. Afterward, based on these data, the use and the cost of various outpatient diagnostic procedures for CVDs were estimated for the total population of Isfahan province. The list of outpatient diagnostic procedures for CVDs was carefully chosen according to experts' opinions.
RESULTS RESULTS
The use and the cost of outpatient diagnostic procedures for CVDs have drastically increased in the study period (2011-2017). Since 2011, the number of procedures and their related costs have increased 6.6 and 30.76 times (11.74 times, adjusted with PPP conversion factor), respectively. Per capita use (per thousand people) was 18.75 in 2011, reaching 116.51 in 2017. Per capita cost (per thousand people) was 1,887,660 IRR (355 PPP$) in 2011, reaching 54,660,365 IRR (3920 PPP$) in 2017. The highest cost and use were related to echocardiography and electrocardiography, respectively. A notable increase has been observed in the share of radionuclide myocardial perfusion scan and analysis of pacemakers and ICDs of the total cost.
CONCLUSIONS CONCLUSIONS
The use of outpatient diagnostic procedures for CVDs has drastically increased during the studied period. Consequently, the cost borne by the health system and the patients have notably increased. This may be because of the increase in the incidence and prevalence of CVDs during the study period. Greater access to related health services can be mentioned as another reason for this increase. Further research is needed to explain all potential reasons and their importance, which can provoke a suitable health policy reaction.

Identifiants

DOI: 10.4103/jehp.jehp_1749_21 PMID: 36177420 PMC: PMC9514278
pubmed: 36177420
doi: 10.4103/jehp.jehp_1749_21
pii: JEHP-11-245
pmc: PMC9514278
doi:

Types de publication

Journal Article

Langues

eng

Pagination

245

Informations de copyright

Copyright: © 2022 Journal of Education and Health Promotion.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Cost Eff Resour Alloc. 2021 Jan 3;19(1):1
pubmed: 33390167
Int J Prev Med. 2016 Jul 29;7:96
pubmed: 27563432
Indian Heart J. 2017 Jul - Aug;69(4):551-555
pubmed: 28822530
J Geriatr Cardiol. 2020 Jan;17(1):1-8
pubmed: 32133031
J Tehran Heart Cent. 2013 Jan;8(1):1-13
pubmed: 23646042
JAMA Netw Open. 2019 Oct 2;2(10):e1913070
pubmed: 31603486
PLoS One. 2019 Jan 10;14(1):e0210502
pubmed: 30629670
Circulation. 2006 Jan 24;113(3):374-9
pubmed: 16432068
Cardiol Res Pract. 2020 Jun 27;2020:4972346
pubmed: 32676206
Can J Cardiol. 2009 Jun;25(6):e195-202
pubmed: 19536390
J Emerg Nurs. 2011 Jan;37(1):109-12
pubmed: 21237383
J Am Coll Cardiol. 2007 Jun 12;49(23):2283-91
pubmed: 17560294
Ont Health Technol Assess Ser. 2010;10(7):1-40
pubmed: 23074410
Arq Bras Cardiol. 2017 Jul;109(1):39-46
pubmed: 28591251
J Med Econ. 2017 Jun;20(6):555-564
pubmed: 28097904
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175

Auteurs

Reza Rezayatmand (R)

Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Ghasem Yadegarfar (G)

Department of Epidemiology and Biostatistics, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran and School of Medicine, University of Central Lancashire, Preston, United Kingdom.

Masoumeh Ghasemirad (M)

Department of Health Services Management, School of Management and Medical Information Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

Farzaneh Mohammadi (F)

Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Classifications MeSH